Stay updated on Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.

Latest updates to the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNew revision label v3.6.5 appears in the page’s revision history, replacing the previous v3.6.4. This indicates a minor update to the page’s version metadata rather than substantive changes to study details.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision metadata on the page was updated from v3.6.3 to v3.6.4. This reflects a minor update to the page's underlying data or tooling rather than a user-facing change.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, signaling a recent update to the page. This does not alter the visible study details.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays Revision: v3.6.2 in place of the previous Revision: v3.6.0, indicating a minor platform update rather than a change to study details or content.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now indicates that participant recruitment has closed and adds new help sections such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention header formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check81 days agoChange DetectedRevision: v3.5.5 is now shown on the page, indicating a recent update to the study record. The change signals a refresh of the content but does not specify what was altered in this context.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.